Condition
Locally Advanced Basal Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Locally Advanced Basal Cell Carcinoma clinical trials that are recruiting, at sites in 6 countries (most in United States (3), Germany (2), Greece (2)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 6Countries
Newest Locally Advanced Basal Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| L19IL2/L19TNF in Locally Advanced Basal Cell Carcinoma | Phase 2 | Tampa, Florida and 17 other locations | Recruiting | Nov 13, 2025 |
| L19IL2, L19TNF, or both for locally advanced basal cell carcinoma | Phase 2 | Tampa, Florida and 17 other locations | Recruiting | Nov 12, 2025 |
| Off-label insurance coverage and care delays for people with advanced skin cancers | — | Columbus, Ohio | Recruiting | Oct 14, 2025 |
| Evaluating oral hedgehog inhibitors for treating basal cell carcinoma in the Netherlands | — | Nijmegen, Gelderland and 7 other locations | Recruiting | Jul 19, 2022 |
All recruiting trials (4)
-
L19IL2/L19TNF in Locally Advanced Basal Cell Carcinoma
This trial tests whether injecting L19IL2/L19TNF directly into injectable skin lesions can help patients with locally advanced basal cell carcinoma who have progressed on or cannot tolerate other treatments.
-
L19IL2, L19TNF, or both for locally advanced basal cell carcinoma
This study tests whether injecting L19IL2, L19TNF, or the combination into skin tumors helps people with locally advanced basal cell carcinoma who can’t have surgery or radiation.
-
Off-label insurance coverage and care delays for people with advanced skin cancers
This study will see if adults with resectable advanced skin cancers face longer approval times, higher out-of-pocket costs, or different surgical outcomes when given off-label versus on-label neoadjuvant treatments.
-
Evaluating oral hedgehog inhibitors for treating basal cell carcinoma in the Netherlands
This study is testing if two oral medications, vismodegib and sonidegib, can help people with advanced basal cell carcinoma or Gorlin syndrome feel better and improve their condition.
Related topics
Quick answers
How many Locally Advanced Basal Cell Carcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (3 trials), Germany (2 trials), Greece (2 trials), Italy (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.